Apogee Therapeutics, Inc. (APGE)
About Apogee Therapeutics, Inc.
Apogee Therapeutics Inc is a clinical-stage biotechnology company engaged in advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other I&I indications. . Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Net income
- -$255.8M
- Total assets
- $937.1M
- Market cap
- $6.6B
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $0
- Operating expenses
- $285.6M
- Operating income
- -$285.6M
- Income tax
- $278.0K
- Net income
- -$255.8M
- EPS (basic)
- $-4.22
- EPS (diluted)
- $-4.22
Balance sheet
- Total assets
- $937.1M
- Current assets
- $741.4M
- Total liabilities
- $33.3M
- Current liabilities
- $27.9M
- Shareholders’ equity
- $903.9M
Cash flow
- Operating cash flow
- -$227.4M
- Investing cash flow
- -$179.6M
- Financing cash flow
- $396.5M
- Net cash flow
- -$10.5M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $6.6B
- EPS (diluted)
- $-4.22
- Shares outstanding
- 48.8M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Jul 14, 2023
Apogee Therapeutics, Inc. (APGE) Stock Price
- Reported a net loss of $255.8M.
- Trading near its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Apogee Therapeutics, Inc..
Write a review
News about Apogee Therapeutics, Inc.
News & sentiment via Polygon.io
Apogee Therapeutics, Inc.: frequently asked questions
Is Apogee Therapeutics, Inc. an American company?
Apogee Therapeutics, Inc. is a US-based company headquartered in Waltham, Massachusetts, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Apogee Therapeutics, Inc. headquartered?
Apogee Therapeutics, Inc. is headquartered in Waltham, Massachusetts, United States.
Is Apogee Therapeutics, Inc. publicly traded?
Yes — Apogee Therapeutics, Inc. is a publicly traded company. Its stock trades under the ticker symbol APGE on the NASDAQ.
What does Apogee Therapeutics, Inc. do?
Apogee Therapeutics, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.
